First Time Loading...
N

NeoPharm Co Ltd
KOSDAQ:092730

Watchlist Manager
NeoPharm Co Ltd
KOSDAQ:092730
Watchlist
Price: 25 950 KRW -1.33% Market Closed
Updated: May 13, 2024
Section:
 

Relative Value

The Relative Value of one NeoPharm Co Ltd stock under the Base Case scenario is 17 083.1 KRW. Compared to the current market price of 25 950 KRW, NeoPharm Co Ltd is Overvalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
17 083.1 KRW
Overvaluation 34%
Relative Value
Price
N
Worst Case
Base Case
Best Case

Valuation Multiples

2.1
P/S
P/S
Price to Sales
2.1
vs History
63
vs Industry
27
Median 3Y
2.1
Median 5Y
2.3
Industry
1.1
Forward
1.7
More Details
8.7
P/E
P/E
Price to Earnings
8.7
vs History
73
vs Industry
53
Median 3Y
9.5
Median 5Y
10.7
Industry
18.2
Forward
9.5
More Details
8.7
P/OCF
P/OCF
Price to OCF
8.7
vs History
57
vs Industry
41
Median 3Y
8.7
Median 5Y
9.6
Industry
11.7
More Details
107.7
P/FCFE
P/FCFE
Price to FCFE
107.7
vs History
0
vs Industry
4
Median 3Y
10.9
Median 5Y
11.2
Industry
17.2
More Details
1.3
P/B
P/B
Price to Book Value
1.3
vs History
68
vs Industry
50
Median 3Y
1.3
Median 5Y
1.6
Industry
1.6
More Details
0.9
EV/S
EV/S
Enterprise Value to Sales
0.9
vs History
55
vs Industry
54
Median 3Y
0.9
Median 5Y
1.1
Industry
1.2
Forward
0.8
More Details
1.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.4
vs History
52
vs Industry
73
Median 3Y
1.3
Median 5Y
1.6
Industry
3.9
More Details
3.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.4
vs History
57
vs Industry
63
Median 3Y
3.2
Median 5Y
4.1
Industry
10.8
Forward
3.2
More Details
3.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
3.6
vs History
57
vs Industry
61
Median 3Y
3.4
Median 5Y
4.3
Industry
13.8
Forward
3.2
More Details
3.9
EV/OCF
EV/OCF
Enterprise Value to OCF
3.9
vs History
55
vs Industry
58
Median 3Y
3.7
Median 5Y
4.6
Industry
11.8
More Details
37.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
37.5
vs History
0
vs Industry
12
Median 3Y
3.9
Median 5Y
6.8
Industry
15.4
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
69
vs Industry
36
Median 3Y
1.8
Median 5Y
2.7
Industry
1.3
More Details

Multiples Across Competitors

Competitors Multiples
NeoPharm Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
NeoPharm Co Ltd
KOSDAQ:092730
202.9B KRW 2.1 8.7 3.4 3.6
FR
L'Oreal SA
PAR:OR
243.6B EUR 5.9 39.4 26.1 31.9
UK
Unilever PLC
LSE:ULVR
107.9B GBP 2.1 19.3 198.1 229.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 9 53.8 36.9 40.1
US
Estee Lauder Companies Inc
NYSE:EL
47.7B USD 3.1 74.7 24.6 40.2
UK
HALEON PLC
LSE:HLN
30.3B GBP 2.7 28 12.9 14.5
DE
Beiersdorf AG
XETRA:BEI
33.5B EUR 3.5 45.5 17.2 22.9
JP
Kao Corp
TSE:4452
3.2T JPY 2.1 72.7 17.8 36.1
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.4T INR 9.9 76.8 45.1 49.5
JP
Shiseido Co Ltd
TSE:4911
1.9T JPY 1.9 85.6 20.7 101.6
IN
Dabur India Ltd
NSE:DABUR
974.8B INR 7.9 54.3 41.4 49.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.